Muszbek L - Search Results

1

Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort.

Gindele R, Oláh Z, Ilonczai P, Speker M, Udvari Á, Selmeczi A, Pfliegler G, Marján E, Kovács B, Boda Z, Muszbek L, Bereczky Z. Gindele R, et al. Among authors: muszbek l. J Thromb Haemost. 2016 Apr;14(4):704-15. doi: 10.1111/jth.13252. Epub 2016 Feb 16. J Thromb Haemost. 2016. PMID: 26748602 Free article.

2

Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report.

Boda Z, Pfliegler G, Muszbek L, Tóth A, Adány R, Hársfalvi J, Papp Z, Tornai I, Rak K. Boda Z, et al. Among authors: muszbek l. Haemostasis. 1989;19(6):348-52. doi: 10.1159/000216082. Haemostasis. 1989. PMID: 2620871

3

Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.

Muszbek L, Adány R, Kávai M, Boda Z, Lopaciuk S. Muszbek L, et al. Thromb Haemost. 1988 Apr 8;59(2):231-5. Thromb Haemost. 1988. PMID: 2898817

4

[A case of FXIII (fibrin stabilizing factor, Laki-Lóránd factor) deficiency].

Boda Z, Muszbek L, Hársfalvi J, Tóth A, Pfliegler G, Tornai I, Rák K. Boda Z, et al. Among authors: muszbek l. Orv Hetil. 1988 Oct 9;129(41):2199-202. Orv Hetil. 1988. PMID: 3054695 Review. Hungarian. No abstract available.

5

Platelet factor XIII becomes active without the release of activation peptide during platelet activation.

Muszbek L, Polgár J, Boda Z. Muszbek L, et al. Thromb Haemost. 1993 Mar 1;69(3):282-5. Thromb Haemost. 1993. PMID: 8097064

6

Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.

Hevessy Z, Haramura G, Boda Z, Udvardy M, Muszbek L. Hevessy Z, et al. Among authors: muszbek l. Thromb Haemost. 1996 Jan;75(1):161-7. Thromb Haemost. 1996. PMID: 8713796

7

High prevalence of factor V Leiden mutation and 20210A prothrombin variant in Hungary.

Balogh I, Póka R, Pfliegler G, Dékány M, Boda Z, Muszbek L. Balogh I, et al. Among authors: muszbek l. Thromb Haemost. 1999 Apr;81(4):660-1. Thromb Haemost. 1999. PMID: 10235459 No abstract available.

8

Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function.

Kerényi A, Schlammadinger A, Ajzner E, Szegedi I, Kiss C, Pap Z, Boda Z, Muszbek L. Kerényi A, et al. Among authors: muszbek l. Thromb Res. 1999 Dec 15;96(6):487-92. doi: 10.1016/s0049-3848(99)00152-8. Thromb Res. 1999. PMID: 10632473 Clinical Trial. No abstract available.

9

Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.

Schlammadinger A, Kerenyi A, Muszbek L, Boda Z. Schlammadinger A, et al. Among authors: muszbek l. Thromb Haemost. 2000 Jul;84(1):88-92. Thromb Haemost. 2000. PMID: 10928476

10

Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.

Balogh I, Szôke G, Kárpáti L, Wartiovaara U, Katona E, Komáromi I, Haramura G, Pfliegler G, Mikkola H, Muszbek L. Balogh I, et al. Among authors: muszbek l. Blood. 2000 Oct 1;96(7):2479-86. Blood. 2000. PMID: 11001900 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters